Every material Form 8-K Healthcare Services Group has filed with the SEC since October 25, 2023, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Healthcare Services Group reported third-quarter 2026 revenue of $479.6 million, up from $464.3 million a year earlier, but net income fell to $24.9 million from $43.0 million and diluted EPS fell to $0.36 from $0.59. The company also raised its 2027 revenue growth outlook to low double-digits from mid single-digits and completed the $93.5 million acquisition of NEXDINE Hospitality on October 6, 2026.
Q3 revenue was $479.6 million versus $464.3 million a year earlier; income from operations was $31.9 million versus $45.9 million.
Net income was $24.9 million ($0.36 diluted EPS) versus $43.0 million ($0.59) a year earlier; Adjusted EBITDA was $38.6 million versus $56.4 million.
The company raised its 2027 revenue growth outlook from mid single-digits to low double-digits and expects fourth-quarter revenue of $535 to $545 million.
Under its February 2026 plan, the company repurchased $11.7 million of common stock in the third quarter and has $56.6 million repurchased year to date.
Healthcare Services Group agreed on October 6, 2026 to buy NexDine, LLC and Xendella, LLC (together NEXDINE Hospitality) for an aggregate price of approximately $93.5 million, plus contingent payments tied to performance conditions. The company paid the cash due at closing from cash on hand, and its press release says the business is expected to contribute over $150 million in annual revenue. The deal expands the company's presence in senior living and hospitality services, but the filing does not disclose the acquired business's profit.
Purchase Agreement dated October 6, 2026 with Real Artisan Brands, LLC and other seller parties
Aggregate price of approximately $93.5 million, subject to customary adjustments, plus contingent consideration
Funded with cash on hand; press release says NEXDINE is expected to contribute over $150 million in annual revenue
NEXDINE will remain a wholly-owned subsidiary headquartered in Mansfield, Massachusetts, led by Founder and CEO David Lanci
Healthcare Services Group reported second quarter 2026 revenue of $470.8 million, up from $458.5 million a year earlier, and net income of $22.7 million, or $0.32 diluted EPS, compared with a net loss of $32.4 million in the same quarter of 2025. The company reaffirmed its 2026 mid-single-digit growth outlook and repurchased $20.9 million of stock in the quarter, which matters to shareholders because revenue and profit both improved while cash flow from operations of $21.9 million fell from $28.8 million a year earlier.
Revenue of $470.8 million for the three months ended June 30, 2026, versus $458.5 million a year earlier
Net income of $22.7 million and diluted EPS of $0.32, versus a net loss of $32.4 million and $(0.44) a year earlier
Cash flow from operations of $21.9 million; $27.9 million excluding the change in payroll accrual
Repurchased $20.9 million of stock in the quarter under a $75.0 million plan running through January 2027; 8.3 million shares remain under the February 2026 authorization
Healthcare Services Group reported first-quarter 2026 revenue of $462.8 million, up 3.4% from the prior year, and net income of $26.1 million, or $0.37 per diluted share, compared with $17.2 million, or $0.23, a year earlier. The company reiterated its 2026 mid-single-digit revenue growth outlook and repurchased $24.0 million of its stock during the quarter.
Revenue of $462.8 million, up 3.4% from $447.7 million in the first quarter of 2025
Net income of $26.1 million and diluted EPS of $0.37, versus $17.2 million and $0.23 a year earlier
Cash flow from operations of $43.7 million; $23.4 million excluding the change in payroll accrual
Repurchased $24.0 million of stock; 9.2 million shares remain under the February 2026 authorization
Healthcare Services Group entered into a Second Amendment to its existing credit agreement with PNC Bank as administrative agent, extending the maturity date to April 7, 2031 and adding a daily SOFR rate option. The filing describes the credit facility as $300 million, and the remaining terms of the agreement stay in effect, so shareholders are mainly seeing a longer debt maturity and added rate flexibility rather than a new obligation of a different kind.
Second Amendment dated April 7, 2026 to the Credit Agreement originally dated December 21, 2018, as amended November 22, 2022
Maturity date extended to April 7, 2031
Added a daily SOFR rate option; PNC Bank, National Association is administrative agent
Filed as Exhibit 10.1; certain schedules and exhibits omitted under Item 601(a)(5) of Regulation S-K
Healthcare Services Group reported fourth-quarter 2025 revenue of $466.7 million, up 6.6%, and net income of $31.2 million, or $0.44 per diluted share, versus $0.16 a year earlier. For the full year, revenue rose 7.1% to $1.84 billion and diluted EPS was $0.81, up from $0.53, and the company expects mid-single-digit revenue growth in 2026. The board also authorized a new buyback of up to 10.0 million shares, with the company planning to repurchase $75.0 million of stock over the next 12 months.
Q4 2025 revenue $466.7 million, up 6.6%; net income $31.2 million, diluted EPS $0.44 versus $0.16 in Q4 2024
Full-year 2025 revenue $1.84 billion, up 7.1%; diluted EPS $0.81 versus $0.53 in 2024
New buyback authorizes up to 10.0 million shares; company plans to repurchase $75.0 million over the next 12 months
2026 outlook calls for mid-single-digit revenue growth; Q4 cash flow from operations was $17.4 million, or $36.4 million excluding the payroll accrual change
Healthcare Services Group reported third-quarter 2025 revenue of $464.3 million, up 8.5% from the prior year, and net income of $43.0 million, or $0.59 per diluted share, compared with $14.0 million, or $0.19, a year earlier. The filing says the results include a $0.36 per share benefit, primarily from the Employee Retention Credit, partly offset by a previously announced Genesis charge, so the profit gain is not all from operations.
Revenue of $464.3 million for the three months ended September 30, 2025, up 8.5% from the prior year
Net income of $43.0 million and diluted EPS of $0.59, including a $0.36 per share benefit primarily related to the Employee Retention Credit
Cash flow from operations of $71.3 million, including a $31.8 million Employee Retention Credit benefit
Share repurchases of $27.3 million in the quarter under a $50.0 million plan running through June 2026
Healthcare Services Group reported second-quarter revenue of $458.5 million, up 7.6% from a year earlier, but posted a net loss of $32.4 million, or $0.44 per diluted share, compared with a net loss of $1.8 million a year earlier. The loss includes a $0.65 per share non-cash charge tied to the previously announced Genesis HealthCare restructuring. The company raised its 2025 cash flow from operations forecast, excluding the change in payroll accrual, and announced a $50.0 million share repurchase plan over the next 12 months.
Revenue of $458.5 million for the three months ended June 30, 2025, up 7.6% over the prior year
Net loss of $32.4 million, or $0.44 per diluted share, including a $0.65 per share non-cash Genesis restructuring charge ($61.2 million pretax)
2025 cash flow from operations forecast, excluding payroll accrual changes, raised to $70.0 to $85.0 million from $60.0 to $75.0 million
Board-authorized plan to repurchase $50.0 million of common stock over 12 months; $7.6 million repurchased in the second quarter
Healthcare Services Group reported first-quarter 2025 revenue of $447.7 million, up 5.7% from the prior year, with net income of $17.2 million, or $0.23 per diluted share, versus $15.3 million, or $0.21, a year earlier. The company raised its 2025 cash flow from operations forecast (excluding the change in payroll accrual) to $60.0 million to $75.0 million from $45.0 million to $60.0 million, while reiterating mid-single digit revenue growth expectations.
Revenue of $447.7 million, up from $423.4 million in the first quarter of 2024
Net income of $17.2 million and diluted EPS of $0.23, compared with $15.3 million and $0.21 a year earlier
Cash flow from operations excluding payroll accrual change of $32.1 million, versus a negative $9.2 million a year earlier
2025 cash flow from operations forecast raised to $60.0 million to $75.0 million; company repurchased about $7.0 million of stock in the quarter
Healthcare Services Group reported fourth-quarter 2024 revenue of $437.8 million, up from $423.8 million a year earlier, but net income fell to $11.9 million from $23.5 million, with diluted EPS of $0.16 versus $0.32. The company guided to mid-single digit revenue growth in 2025 and first-quarter 2025 revenue of $440.0 to $450.0 million, which gives shareholders a near-term outlook alongside a sharp drop in quarterly profit.
Q4 2024 revenue was $437.8 million versus $423.8 million in Q4 2023; net income was $11.9 million versus $23.5 million, inclusive of new business start-up costs.
Full-year 2024 revenue was $1.72 billion versus $1.67 billion in 2023; full-year diluted EPS was $0.53 versus $0.52.
2025 outlook: mid-single digit revenue growth, Q1 2025 revenue of $440.0 to $450.0 million, and cash flow from operations excluding the payroll accrual change of $45.0 to $60.0 million.
Cash and marketable securities were $135.8 million at year-end, and the company has repurchased over $16.0 million of stock since February 2023.
Healthcare Services Group reported third-quarter 2024 revenue of $428.1 million, up from $411.4 million a year earlier, and net income of $14.0 million, or $0.19 per diluted share, compared with a net loss of $5.0 million, or $0.07 per share, in the same quarter of 2023. The company reaffirmed its fourth-quarter revenue estimate of $430.0 million to $440.0 million and its 2024 adjusted cash flow from operations forecast of $40.0 million to $55.0 million.
Q3 2024 revenue of $428.1 million, up from $411.4 million in Q3 2023 and within the company's $425.0 million to $435.0 million expectation range.
Net income of $14.0 million, or $0.19 per diluted share, versus a net loss of $5.0 million, or $0.07 per share, a year earlier.
Reaffirmed Q4 2024 revenue estimate of $430.0 million to $440.0 million and 2024 adjusted cash flow from operations forecast of $40.0 million to $55.0 million.
Adjusted EBITDA of $24.8 million; cash and marketable securities of $130.0 million as of September 30, 2024.
Healthcare Services Group appointed Vikas Singh as Executive Vice President and Chief Financial Officer, effective September 3, 2024. Andrew Brophy, previously Principal Financial & Accounting Officer, was promoted to Senior Vice President, Controller and Chief Accounting Officer, per the press release. A CFO change is a significant leadership event, and Singh will oversee accounting, finance, corporate development and investor relations.
Vikas Singh, age 47, joins as EVP and CFO effective September 3, 2024, after serving as Managing Director at Bank of America Securities
Singh previously worked at Credit Suisse and Citibank, and began his career at GSK's Consumer Healthcare Division
Andrew Brophy named SVP, Controller and Chief Accounting Officer; he joined the Company in 2018
Healthcare Services Group reported a second-quarter net loss of $1.8 million, or $0.02 per diluted share, compared with net income of $8.3 million a year earlier, even though revenue rose to $426.3 million. The company said the loss reflects client restructuring charges, including those tied to the LaVie Care Centers Chapter 11 filing. The company raised its third- and fourth-quarter revenue estimates and reaffirmed its 2024 adjusted cash flow forecast of $40.0 million to $55.0 million.
Q2 2024 revenue was $426.3 million, up from $418.9 million in Q2 2023 and in line with the company's expectation of $420.0 million to $430.0 million.
Net loss of $1.8 million, or $0.02 per diluted share, versus net income of $8.3 million, or $0.11 per diluted share, in Q2 2023; results include a $0.22 per share impact from client restructuring bad debt expense.
Q3 2024 revenue estimate raised to $425.0 million to $435.0 million; Q4 2024 estimate raised to $430.0 million to $440.0 million.
2024 adjusted cash flow from operations forecast of $40.0 million to $55.0 million reaffirmed; Q2 adjusted cash flow used in operations was $2.4 million.
Healthcare Services Group reported first-quarter 2024 results on April 24, 2024. Revenue rose to $423.4 million from $417.2 million, net income rose to $15.3 million from $11.7 million, and diluted EPS was $0.21 versus $0.16 a year earlier. The company reiterated its 2024 adjusted cash flow range of $40.0 million to $55.0 million, but said the February Change Healthcare cyberattack disrupted customer collections during the quarter.
Revenue of $423.4 million compared with $417.2 million in the first quarter of 2023
Net income of $15.3 million and diluted EPS of $0.21, versus $11.7 million and $0.16 a year earlier
Cash flows used in operating activities were $26.0 million for the quarter
2024 adjusted cash flow from operations range of $40.0 million to $55.0 million reiterated
Healthcare Services Group reported fourth-quarter 2023 GAAP net income of $22.6 million, or $0.31 per diluted share, up from $16.2 million, or $0.22, a year earlier. GAAP revenue was $423.8 million, roughly flat compared with $424.0 million in the prior-year quarter, and the company expects first-quarter 2024 revenue of $420.0 million to $430.0 million, so shareholders see higher profit on essentially unchanged sales.
Q4 2023 GAAP net income was $22.6 million, or $0.31 per diluted share, versus $16.2 million, or $0.22, in Q4 2022.
Q4 2023 GAAP revenue was $423.8 million, compared with $424.0 million in Q4 2022; adjusted revenue was $425.0 million.
Q4 2023 adjusted EBITDA was $26.5 million, a 14.2% increase over Q4 2022, and cash flow from operations was $49.5 million.
The company estimates first-quarter 2024 revenue in the range of $420.0 million to $430.0 million and repurchased $11.2 million of stock in 2023.
Healthcare Services Group reported a GAAP net loss of $5.5 million, or $(0.07) per diluted share, for the quarter ended September 30, 2023, compared with net income of $0.3 million a year earlier. Excluding non-GAAP adjustments, including $21.7 million of client restructuring charges, adjusted diluted EPS was $0.17, up 13.3%, and the company raised its second-half 2023 operating cash flow expectation to $35.0 million to $45.0 million.
GAAP revenue was $411.4 million versus $414.5 million in Q3 2022; adjusted revenue was $424.0 million.
Net loss of $5.5 million, or $(0.07) per diluted share, compared with net income of $0.3 million in Q3 2022.
Adjusted diluted EPS of $0.17 versus $0.15 a year earlier; adjusted cash flow from operations was $18.0 million.
Second-half 2023 cash flow from operations expectation raised to $35.0 million to $45.0 million from $20.0 million to $30.0 million.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Healthcare Services Group filing is on SEC EDGAR ↗. 8-K briefs of other companies →